Tag: Antibody
ImmunoQure And Memo Therapeutics Collaborate To Biobank Rare Disease Autoantibodies
ImmunoQure AG, a biotechnology company focused on the
development of autoantibodies as therapeutics to treat human diseases and Memo
Therapeutics AG, a biotechnology company focused on the discovery and
development of therapeutic antibodies from cognate paired antibody libraries have
established a collaborative partnership...
Memo Therapeutics Takes A Major Step In High-Throughput Functional Antibody Screening
Memo Therapeutics has announced the development of a droplet sorter that enables functional antibody screening in a high-throughput format.
Founded in 2012, located in the Greater Zürich Area, Switzerland, Memo Therapeutics AG is an innovator in the field of antibody...
Teneobio and Selexis Partner To Develop Manufacturing Grade Oncology-Targeting Research Cell Banks
Selexis SA and Teneobio, Inc. have announced that they have
entered into a second services agreement to expand Teneobio’s oncology pipeline
of Human Heavy-Chain Antibodies (UniAbs™), a new class of multi-specific
biologics. Under the agreement, Teneobio will utilize Selexis’ proprietary
SUREtechnology Platform™ to...
